DVA vs NRIX · P/E 14, rev $12.82B vs rev $54.5M
DaVita HealthCare Partners Inc (DVA) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the DVA and NRIX stock pages for the full models.
Not investment advice.